Response by Chao et al to Letters Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
From Division of Cardiology, Department of Medicine (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.), Division of Hematology and Oncology (C.-J.L.), and Department of Family Medicine (T.-J.C.), Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.); Institute of Public Health and School of Medicine, National Yang-Ming University, Taipei, Taiwan (C.-J.L.); and University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L.).
Tze-Fan
TF
Chao
From Division of Cardiology, Department of Medicine (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.), Division of Hematology and Oncology (C.-J.L.), and Department of Family Medicine (T.-J.C.), Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.); Institute of Public Health and School of Medicine, National Yang-Ming University, Taipei, Taiwan (C.-J.L.); and University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L.).
Chia-Jen
CJ
Liu
From Division of Cardiology, Department of Medicine (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.), Division of Hematology and Oncology (C.-J.L.), and Department of Family Medicine (T.-J.C.), Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.); Institute of Public Health and School of Medicine, National Yang-Ming University, Taipei, Taiwan (C.-J.L.); and University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L.).
Jo-Nan
JN
Liao
From Division of Cardiology, Department of Medicine (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.), Division of Hematology and Oncology (C.-J.L.), and Department of Family Medicine (T.-J.C.), Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.); Institute of Public Health and School of Medicine, National Yang-Ming University, Taipei, Taiwan (C.-J.L.); and University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L.).
Kang-Ling
KL
Wang
From Division of Cardiology, Department of Medicine (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.), Division of Hematology and Oncology (C.-J.L.), and Department of Family Medicine (T.-J.C.), Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.); Institute of Public Health and School of Medicine, National Yang-Ming University, Taipei, Taiwan (C.-J.L.); and University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L.).
Yenn-Jiang
YJ
Lin
From Division of Cardiology, Department of Medicine (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.), Division of Hematology and Oncology (C.-J.L.), and Department of Family Medicine (T.-J.C.), Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.); Institute of Public Health and School of Medicine, National Yang-Ming University, Taipei, Taiwan (C.-J.L.); and University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L.).
Shih-Lin
SL
Chang
From Division of Cardiology, Department of Medicine (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.), Division of Hematology and Oncology (C.-J.L.), and Department of Family Medicine (T.-J.C.), Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.); Institute of Public Health and School of Medicine, National Yang-Ming University, Taipei, Taiwan (C.-J.L.); and University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L.).
Li-Wei
LW
Lo
From Division of Cardiology, Department of Medicine (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.), Division of Hematology and Oncology (C.-J.L.), and Department of Family Medicine (T.-J.C.), Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.); Institute of Public Health and School of Medicine, National Yang-Ming University, Taipei, Taiwan (C.-J.L.); and University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L.).
Yu-Feng
YF
Hu
From Division of Cardiology, Department of Medicine (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.), Division of Hematology and Oncology (C.-J.L.), and Department of Family Medicine (T.-J.C.), Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.); Institute of Public Health and School of Medicine, National Yang-Ming University, Taipei, Taiwan (C.-J.L.); and University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L.).
Ta-Chuan
TC
Tuan
From Division of Cardiology, Department of Medicine (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.), Division of Hematology and Oncology (C.-J.L.), and Department of Family Medicine (T.-J.C.), Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.); Institute of Public Health and School of Medicine, National Yang-Ming University, Taipei, Taiwan (C.-J.L.); and University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L.).
Fa-Po
FP
Chung
From Division of Cardiology, Department of Medicine (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.), Division of Hematology and Oncology (C.-J.L.), and Department of Family Medicine (T.-J.C.), Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.); Institute of Public Health and School of Medicine, National Yang-Ming University, Taipei, Taiwan (C.-J.L.); and University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L.).
Tzeng-Ji
TJ
Chen
From Division of Cardiology, Department of Medicine (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.), Division of Hematology and Oncology (C.-J.L.), and Department of Family Medicine (T.-J.C.), Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.); Institute of Public Health and School of Medicine, National Yang-Ming University, Taipei, Taiwan (C.-J.L.); and University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L.).
Gregory Y H
GY
Lip
From Division of Cardiology, Department of Medicine (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.), Division of Hematology and Oncology (C.-J.L.), and Department of Family Medicine (T.-J.C.), Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan (T.-F.C., J.-N.L., K.-L.W., Y.-J.L., S.-L.C., L.-W.L., Y.-F.H., T.-C.T., F.-P.C., S.-A.C.); Institute of Public Health and School of Medicine, National Yang-Ming University, Taipei, Taiwan (C.-J.L.); and University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L.).
Shih-Ann
SA
Chen
D000284:Administration, Oral; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000188:drug therapy; D006470:Hemorrhage / Q000188:drug therapy; D006801:Humans; D020300:Intracranial Hemorrhages / Q000188:drug therapy; D020521:Stroke / Q000188:drug therapy; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin